Possible association between actinic keratosis and the rs7208422 (c.917A→T, p.N306l) polymorphism of the EVER2 gene in patients without epidermodysplasia verruciformis

Clinical and Experimental Dermatology

Volumn 40, Issue 3, 2015, Pages 318-323

  Kalinska Bienias, A ^a   Kostrzewa, G ^a   Malejczyk, M ^a   Ploski, R ^a   Majewski, S ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EPIDERMODYSPLASIA VERRUCIFORMIS; EVER2 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AGED; CASE CONTROL STUDY; GENE FREQUENCY; GENETICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; VERY ELDERLY;

MEMBRANE PROTEIN; TMC8 PROTEIN, HUMAN;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KERATOSIS, ACTINIC; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC;

EID: 84924574481     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12506     Document Type: Article

References (23)

1. Orth G,. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006; 18: 362-74.
2. Pfister H, Fuchs PG, Majewski S, et al,. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 2003; 295: 273-9.
3. Glogau RG,. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: 23-4.
4. Jeffes EW, Tang EH,. Actinic keratosis. Current treatment options. Am J Clin Dermatol 2000; 1: 167-79.
5. Berhane T, Halliday GM, Cooke B, Barnetson RS,. Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol 2002; 146: 810-15.
6. Ramoz N, Rueda LA, Bouadjar B, et al,. Mutations in two adjacent novel genes are associated with epidermodys-plasia verruciformis. Nat Genet 2002; 32: 579-81.
7. Arnold AW, Burger B, Kump E, et al,. Homozygosity for the c.917A->T (p. N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz. Dermatology 2011; 222: 81-6.
8. Hohenstein E, Rady PL, Hergersberg M, et al,. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A->T polymorphism in the TMC8/EVER2 gene. Dermatology 2009; 218: 114-18.
9. Zuo YG, Ma D, Zhang Y, et al,. Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis. J Dermatol Sci 2006; 44: 153-9.
10. de Oliveira WR, Rady PL, Grady J, et al,. Polymorphisms of the interleukin 10 gene promoter in patients from Brazil with epidermodysplasia verruciformis. J Am Acad Dermatol 2003; 49: 639-43.
11. Patel AS, Karagas MR, Pawlita M, et al,. Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int J Cancer 2008; 122: 2377-9.
12. Quinn AG, Sikkink S, Rees JL,. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res 1994; 54: 4756-9.
13. Rehman I, Takata M, Wu YY, Rees JL,. Genetic change in actinic keratosis. Oncogene 1996; 12: 2483-90.
14. Obradovic J, Jurisic V, Tosic N, et al,. Optimization of PCR conditions for amplification of GC-Rich EGFR promoter sequence. J Clin Lab Anal 2013; 27: 487-93.
15. Hansen SK, Gjesing AP, Rasmussen SK, et al,. Large-scale studies of the insulin gene variable-number-of-tandem-repeats polymorphism in relation to Type 2 diabetes mellitus and insulin release. Diabetologia 2004; 47: 1079-87.
16. zur Hausen H,. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996; 1288: F55-78.
17. Wang SS, Gonzalez P, Yu K, et al,. Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS ONE 2010; 5: e8667.
18. Castro FA, Ivansson EL, Schmitt M, et al,. Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility. Int J Cancer 2012; 130: 349-55.
19. Uribe P, Gonzalez S,. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy. Pathol Res Pract 2011; 207: 337-42.
20. Toll A, Salgado R, Yébenes M, et al,. Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas. Exp Dermatol 2010; 19: 151-3.
21. Hermanns JF, Piérard GE, Quatresooz P,. Erlotinib-responsive actinic keratoses. Oncol Rep 2007; 18: 581-4.
22. Gaffney DC, Soyer HP, Simpson F,. The epidermal growth factor receptor in squamous cell carcinoma: an emerging drug target. Australas J Dermatol 2014; 55: 24-34.
23. Lazarczyk M, Pons C, Mendoza JA, et al,. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 2008; 205: 35-42.